Ameliorative role of naringenin in MPTP- induced Parkinsonism: Insights from Drosophila melanogaster experimental model combined with computational biology
Open Access
- 21 March 2025
- journal article
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102004
Abstract
No abstract availableKeywords
Funding Information
- International Centre for Genetic Engineering and Biotechnology
- International Center for Genetic Engineering and Biotechnology (CRP/ NGA18-02)
This publication has 94 references indexed in Scilit:
- Cholinergic Inhibition and Antioxidant Potential of Gongronema latifolium Benth Leaf in Neurodegeneration: Experimental and In Silico StudyCell Biochemistry and Biophysics, 2024
- An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment3 Biotech, 2023
- Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained LoopCurrent Neurology and Neuroscience Reports, 2022
- MPTP Parkinsonism and Implications for Understanding Parkinson's DiseaseMovement Disorders Clinical Practice, 2021
- Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomicsMedicinal Research Reviews, 2021
- The Parkinson Pandemic—A Call to ActionJAMA Neurology, 2018
- Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling PathwaysNeurotoxicity Research, 2016
- Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 ExpressionMolecular Neurobiology, 2015
- Protective Effects of Naringenin on Iron-Overload-Induced Cerebral Cortex Neurotoxicity Correlated with Oxidative StressBiological Trace Element Research, 2014
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009